Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 711)
Posted On: 06/26/2021 11:06:57 PM
Post# of 154993
Posted By: ohm20
Re: Goosebumps #94600
Their drug reduces lipids (fat) in the liver by inhibiting the HSD17B13 gene. Lipids will increase inflammation and fibrosis, CCR5 blockade has shown a reduction of lipids and will actively reduce inflammation and the fibrosis that follows.

It's possible that Arrowhead's drug could show positive results in NASH but I think leronlimab would be superior.













(12)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site